« Previous
Next »
The American Journal of Medicine
Volume 120, Issue 8
, Pages 693.e1-693.e8
, August 2007
Acute Reperfusion Therapy in ST-Elevation Myocardial Infarction from 1994-2003
References
- Quality of care in U.S. hospitals as reflected by standardized measures, 2002-2004. N Engl J Med. 2005;353:255–264
- . Care in U.S. hospitals—the Hospital Quality Alliance program. N Engl J Med. 2005;353:265–274
- . Treatment delayed is treatment denied. Circulation. 2004;109:1806–1808
- Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation. 1998;97:1150–1156
- Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000;36:2056–2063
- Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet. 2002;359:373–377
- A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002;23:1190–1201
- A comparison of the National Registry of Myocardial Infarction 2 with the Cooperative Cardiovascular Project. J Am Coll Cardiol. 1999;33:1886–1894
- ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation. 2006;113:732–761
- . Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–322
- . Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771–775
- . The obsession with primary angioplasty. Circulation. 2003;108:e162
- . Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13–20
- Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. Ann Intern Med. 1996;124:283–291
- Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med. 2000;342:1094–1100
- Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005;353:671–682
- Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA. 1997;277:1683–1688
- Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994;331:1136–1142
- . Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction. Eur Heart J. 2006;27:1539–1549
- Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. Am J Cardiol. 1994;73:729–736
- Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283:3223–3229
- ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary (A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)). J Am Coll Cardiol. 2004;44:671–719
- Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks. J Am Coll Cardiol. 2005;45:471–478
- Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med. 1992;327:7–13
- Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294:1240–1247
- . Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA. 2004;291:1864–1870
- . Clinical prognosis, pre-existing conditions and the use of reperfusion therapy for patients with ST segment elevation acute myocardial infarction. Can J Cardiol. 2006;22:131–139
- Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction?. JAMA. 1999;281:714–719
This project was supported by the National Heart, Lung, and Blood Institute (R01 HS072575). Genentech, Inc. (South San Francisco, CA) approved the study and provided access to National Registry of Myocardial Infarction (NRMI) data without charge.
PII: S0002-9343(07)00240-9
doi: 10.1016/j.amjmed.2007.01.028
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 120, Issue 8
, Pages 693.e1-693.e8
, August 2007

